Northern California Chapter

Top Type 1 Diabetes (T1D) Advances of Fiscal Year 2023 Looking back at Fiscal Year 2023, there is much to…

  FDA Clears a New Artificial Pancreas System The U.S. Food and Drug Administration (FDA) cleared the iLet® Insulin-Only Bionic…

  Breakthrough T1D Collaboration Leads to Next-Generation Cell Therapy Research  JDRF is committed to supporting the development of cell replacement therapies that…

Breakthrough T1D Northern California Advocates to be Honored at 2023 Tee to Table Event We’re excited to honor all Breakthrough…

New Clinical Trial Finds Varapamil Slows T1D Progression in Newly Diagnosed Youth A new Breakthrough T1D-funded clinical trial suggests a…

FDA Authorizes Tidepool Loop, an Automated Insulin Dosing App Last month, the U.S. Food & Drug Administration (FDA) authorized the…

Join us for the Breakthrough T1D NorCal Annual Meeting & Research Discussion on February 28 Save the date! On February…

The Global Type 1 Diabetes (T1D) Index The T1D Index is a first-of-its-kind, lifesaving data simulation tool that measures the…

by Zosia Mosur, 14 I was diagnosed with type 1 diabetes (T1D) over two years ago at the age of…

A New Tool to Accurately Diagnose Type 1 Diabetes (T1D) in Adults Researchers have found that up to 20 percent…